Stem Cell Treatment for Fibromyalgia in Delhi, India

Causes

The exact cause of fibromyalgia is not fully understood, but research points to a combination of genetic, neurological, and environmental factors that together lower a person’s pain threshold and disrupt normal pain regulation.

Genetic Predisposition

Fibromyalgia tends to run in families. Certain inherited traits appear to make some individuals more susceptible to heightened pain sensitivity and to mood disorders such as anxiety and depression, both of which are closely linked with the condition.

Physical or Emotional Trauma

A single traumatic event — a car accident, a significant injury, or a severe infection — can act as a trigger that precedes the onset of fibromyalgia symptoms in susceptible individuals. Childhood trauma or repeated early-life stress has also been associated with changes in how the brain processes pain and stress signals later in life.

Post-Traumatic Stress Disorder (PTSD)

Individuals who have experienced significant psychological trauma — such as combat, abuse, or a major accident — show a higher association with fibromyalgia, suggesting a shared link between the body’s stress-response systems and chronic pain regulation.

Sex-Related Factors

Fibromyalgia is significantly more common in women than in men. Researchers believe this may relate to differences in pain perception and processing, along with hormonal and societal factors that influence how pain is experienced and reported.

Mood Disorders

Anxiety and depression frequently co-exist with fibromyalgia. While it is not established that these conditions directly cause fibromyalgia, the overlap suggests shared underlying neurological pathways.

Sedentary Lifestyle

Physical inactivity is associated with a higher prevalence of fibromyalgia. Structured, gentle exercise remains one of the most effective non-drug interventions for managing symptoms and is often recommended alongside any regenerative treatment plan.

Because fibromyalgia frequently coexists with autoimmune and rheumatologic disease, a proper diagnostic workup (see Diagnosis) is essential before considering any therapy, including stem cell treatment.

Symptoms

Fibromyalgia symptoms vary widely between individuals and often fluctuate — some days may bring manageable discomfort while others bring debilitating flare-ups. The hallmark symptom is widespread pain lasting three months or longer, affecting both sides of the body and above and below the waist. Associated symptoms include:

• Persistent, widespread musculoskeletal pain
• Tenderness at specific points on the body (tender points)
• Chronic fatigue, even after a full night’s sleep
• Memory and concentration difficulties (“fibro fog”)
• Sleep disturbances, including non-restorative sleep
• Sleep apnea
• Irritable bowel syndrome (IBS)
• Overlap with systemic lupus erythematosus in some patients
• Bruxism (teeth grinding)
• Headaches and migraines
• Heightened sensitivity to touch, temperature, and light
• Anxiety and depressive symptoms

Because these symptoms mimic several other chronic pain and autoimmune conditions, an accurate diagnosis relies on ruling out overlapping disorders — a process outlined in the Diagnosis section below.

Diagnosis

Fibromyalgia diagnosis is largely clinical, since there is no single laboratory or imaging test that confirms the condition. Instead, physicians rely on a structured process of history-taking, physical examination, and exclusion of other conditions with overlapping symptoms.

Medical History Review

The physician will ask detailed questions about the location, duration, and severity of pain, along with associated symptoms such as fatigue, cognitive difficulty, and sleep quality. Since fibromyalgia often coexists with other conditions, patients are also asked about any additional diagnoses, including autoimmune or joint disorders.

Physical Examination

A hands-on examination checks for tenderness at recognized trigger points and helps rule out conditions with similar presentations, such as rheumatoid arthritis or osteoarthritis.

Exclusionary Blood Work

While no test confirms fibromyalgia directly, blood tests are typically ordered to exclude conditions that can mimic it, such as thyroid disorders, vitamin deficiencies, and inflammatory or autoimmune diseases.

Symptom Duration Criteria

Current diagnostic criteria generally require widespread pain present for at least three months, alongside a defined level of associated symptom severity, following current rheumatology guidelines (see Scientific References).

This thorough evaluation ensures that any subsequent treatment plan — whether conventional management or an investigational stem cell protocol — is built on an accurate diagnostic foundation.

How Stem Cell Therapy for Fibromyalgia Works, Step by Step

Regenerative treatment for fibromyalgia centers on Mesenchymal Stem Cells (MSCs), which are being studied for their potential anti-inflammatory and pain-modulating properties. Rather than only masking pain signals, this investigational approach aims to influence the underlying inflammatory and cellular processes thought to contribute to central sensitization.

The general treatment pathway includes:

1. Qualification for Treatment — A comprehensive review of the patient’s medical history, pain pattern, and prior diagnostic workup (see Diagnosis) to determine candidacy.
2. Source Selection — Depending on the treatment plan, stem cells may be sourced autologously (from the patient’s own bone marrow or adipose tissue) or from an allogeneic donor source such as umbilical cord tissue, with HLA compatibility screening performed for donor-based protocols.
3. Laboratory Processing — Samples are processed in a GMP-compliant, Class 5 biomedical clean-room laboratory, where the cells are cultured, expanded, and formulated into a therapeutic dose. Every batch undergoes quality testing before release (see Quality Certificate).
4. Multi-Stage Administration — Rather than a single infusion, treatment protocols often use a series of staged administrations of MSCs, sometimes combined with Platelet Rich Plasma (PRP), aimed at supporting more targeted regeneration over time.
5. Delivery — Cells are introduced via the route best suited to the patient’s clinical presentation (see Implantation).
6. Aftercare and Monitoring — Patients are tracked through a structured follow-up schedule to assess response.

During periods of tissue stress, the body naturally produces SDF-1 (Stromal Cell-Derived Factor 1), a signaling protein that helps direct cells toward areas requiring repair — a “homing” mechanism that researchers believe may help guide introduced stem cells toward affected tissue. To understand this process at a deeper scientific level, see our Physiological Mechanism of Stem Cells page.

Implantation

Stem cell implantation for fibromyalgia can be carried out through several delivery routes, selected according to the patient’s symptom distribution and overall health:

• Intravenous (IV) administration — allows systemic circulation of cells throughout the body.
• Intrathecal administration (lumbar puncture) — used when central nervous system involvement is a treatment target.
• Intramuscular injection — delivers cells directly into affected muscle tissue.
• Intra-arterial delivery — targets a specific region via the arterial supply.
• Subcutaneous injection — delivered beneath the skin.
• Liberation angioplasty — used in cases involving vascular considerations.
• Surgical administration — reserved for select complex cases, such as those related to stroke recovery.

Each method is chosen with the goal of maximizing the potential for cells to reach affected tissue while minimizing procedural risk. Learn more on our dedicated Stem Cell Delivery Methods page.

Mechanism

Fibromyalgia treatment protocols are built around CD34+ enriched Mesenchymal Stem Cells, administered in a series of staged infusions aimed at highly targeted regeneration rather than a single blanket dose.

The proposed mechanism draws on the body’s own repair signaling: under physical stress, tissues release SDF-1, a protein that recruits neighboring cells to the site of injury and initiates the “homing” process. Researchers believe this same mechanism may help direct newly introduced stem cells — sourced autologously or allogeneically from peripheral blood, umbilical cord blood, placenta, bone marrow, or adipose tissue — toward the tissue regions contributing to a patient’s pain and inflammation.

Ongoing research is also examining whether MSCs can modulate central sensitization, the amplified pain-processing pattern in the central nervous system that is considered central to fibromyalgia, alongside their known anti-inflammatory and paracrine (cell-signaling) properties. For a deeper look at these biological principles, visit Tap here to read more information.

Improvements

By reintroducing processed stem cells into the body, fibromyalgia symptoms may be reduced and overall function improved. Regenerative approaches such as this have been associated with:

1. Improved skin elasticity
2. Enhanced overall quality of life
3. Increased body mobility
4. Reduced inflammation
5. Increased collagen production

By targeting the tissue regions most affected by chronic discomfort and irritation, the aim is to support the body’s own healing and cell-regeneration processes. Patients have reported reduced severity in a number of associated symptoms, including:

• Knee, ankle, and foot pain
• Shoulder and rotator cuff pain
• Bursitis
• Hip and pelvic floor pain
• General chronic discomfort

These reports reflect individual patient experiences rather than guaranteed outcomes, and should be considered alongside the Treatment Results data below.

Our Promise

At Viezec, our commitment to fibromyalgia patients includes:

• Access to all channels of communication throughout treatment — phone, email, and SMS.
• Comprehensive assistance from initial therapeutic strategizing through post-therapy follow-up.
• Strict adherence to internationally recognized safety and quality standards.
• A patient-first approach that prioritizes transparency at every stage of the journey.

To understand why international patients frequently choose India for regenerative treatment, visit Why Stem Cell Therapy in India.

Treatment Results

Stem cells possess anti-inflammatory properties that are being studied for their relevance to autoimmune and chronic pain conditions such as fibromyalgia. Their reported capacity to support healing, repair, and regeneration of tissue — including nerve tissue — is central to the rationale for their use in modulating pain-processing function at a cellular level.

In case reviews, patients who underwent this investigational treatment reported reduced nerve-related pain along with improvements in mobility and stamina. Some patients reported these changes persisting over an extended period without further intervention, though outcomes are inherently individual and not guaranteed for every patient.

For more patient experiences, visit our YouTube channel or see the Testimonials section below.

Testimonials

Priya M. – Delhi, India – February 2020 – ⭐⭐⭐⭐☆
“Chronic body pain from fibromyalgia made life unbearable. After Viezec’s stem cell therapy, my pain reduced, and I finally sleep better.”

Hannah T. – Manchester, UK – July 2020 – ⭐⭐⭐⭐⭐
“Fatigue controlled my life before treatment. Post stem cell therapy at Viezec, my energy levels improved, and I can manage daily chores again.”

Omar R. – Amman, Jordan – December 2020 – ⭐⭐⭐⭐☆
“My wife’s fibromyalgia caused constant stiffness. After therapy at Viezec, she feels relief, and her mobility has improved.”

Isabella G. – Milan, Italy – March 2021 – ⭐⭐⭐⭐⭐
“I was on painkillers for years. Viezec’s stem cell treatment reduced my need for medication and gave me natural relief.”

Ahmed Z. – Cairo, Egypt – September 2021 – ⭐⭐⭐⭐☆
“Daily fatigue and muscle pain stopped me from working. After Viezec’s therapy, I feel stronger and more focused.”

Emily R. – Toronto, Canada – February 2022 – ⭐⭐⭐⭐⭐
“Fibromyalgia left me exhausted and hopeless. Post-treatment at Viezec, my flare-ups reduced, and I feel active again.”

Fatima H. – Casablanca, Morocco – August 2022 – ⭐⭐⭐⭐☆
“My daughter’s pain was constant. Stem cell therapy at Viezec gave her much-needed relief and improved her daily routine.”

Lucas P. – Sydney, Australia – April 2023 – ⭐⭐⭐⭐⭐
“I had widespread muscle pain for years. After therapy at Viezec, I can exercise lightly and enjoy life more fully.”

Maria S. – São Paulo, Brazil – November 2023 – ⭐⭐⭐⭐☆
“Fibromyalgia made simple tasks feel impossible. Post-treatment at Viezec, my stamina improved, and I feel less dependent on others.”

George K. – Athens, Greece – May 2025 – ⭐⭐⭐⭐⭐
“Stem cell therapy at Viezec reduced my pain intensity and improved sleep quality. I finally feel like I have control over my health again.”

Treatment Disclaimer

Before undergoing this procedure, patients should understand that stem cell therapy for fibromyalgia remains an experimental, investigational approach and may not produce the desired effect in every case. Depending on individual evaluation, treatment may be declined, or the proposed protocol may be adjusted based on the patient’s health status.

Our priority is providing the most current, safety-focused techniques available, aligned with recognized international standards. As with any medical treatment, no outcome can be guaranteed — individual biology varies, and results differ from patient to patient even with a similar diagnosis. No embryonic or fetal stem cells are used in any of our treatment protocols.